SPARC acts as a tumor inhibitor in breast cancer, colorectal cancer, ovarian cancer, prostatic cancer and pancreatic cancer [5–11], but in glioma SPARC serves as a tumor promoter via enhancing tumor invasion and metastasis [12]. Here, SPARC is linked to pancreatic neoplasm.